Tuesday, Sep 08th
Last update07:36:37 AM GMT
In spite of this record, an FDA advisory panel voted 5-4 against approving the drug for breast cancer. While studies have shown that Avastin shrinks breast tumors, there is no evidence that it lengthens or improves the quality of patients' lives.
 As a new NFL season begins this Wednesday, the danger of America’s most-watched sport has never... |
| ||
 After recently gaining recognition as the first professional Santa Claus with Down syndrome in the US,... |
 US healthcare officials recently said a food-poisoning outbreak tied to alfalfa sprouts and involving multiple germs... |
